elotuzumab
ItalyDrugs containing this active substance
-
Empliciti is used for the treatment of multiple myeloma (a type of bone marrow cancer) in adults, particularly when the cancer has not responded to or has recurred after other treatments.
Form: powder for concentrate for infusion solution
Active substance Dosage elotuzumab - ATC: L01FX08
Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG